Management characteristics and prognosis after stroke in China:findings from a large nationwide stroke registry

作     者：Haiqiang Qin Yiping Chen Gaifen Liu Iain Turnbull Runhua Zhang Zixiao Li Yilong Wang Liping Liu Xingquan Zhao Zhengming Chen Yongjun Wang 

作者机构：Department of NeurologyBeijing Tiantan HospitalCapital Medical UniversityBeijingChina China National Clinical Research Center for Neurological DiseasesBeijingChina Center of StrokeBeijing Institute for Brain DisordersBeijingChina Beijing Key Laboratory of Translational Medicine for Cerebrovascular DiseaseBeijingChina Medical Research Council Population Health Research UnitNuffield Department of Population HealthUniversity of OxfordOxfordUK Clinical Trial Service Unit&Epidemiological Studies UnitNuffield Department of Population HealthUniversity of OxfordOxfordUK 

出 版 物：《Stroke & Vascular Neurology》 (卒中与血管神经病学（英文）)

年 卷 期：2021年第6卷第1期

页      面：1-9页

核心收录：

学科分类：1002[医学-临床医学] 100204[医学-神经病学] 10[医学] 

基　　金：National Key R&D Plan of the Ministry of Science and Technology of China(2016YFC1301604,2017YFC1307702) National Natural Science Foundation of China(81870907) Ministry of Science and Technology and the Ministry of Health of China(2006BA101A11 and 2009CB521905) Beijing Municipal Administration of Hospitals’Mission Plan(SML20150502) 

主　　题：protective prognosis mortality 

摘      要：Background and purpose There is limited nationwide evidence about the standard management characteristics of stroke types and prognosis in *** study aimed to assess clinical characteristics,in-hospital and after-discharge management characteristics and prognosis for stroke types in *** A nationwide registry recruited 14244 imaging-confirmed first-ever incident strokes from 132 hospitals across 31 provinces of China during 2007-2008,recording presenting characteristics,diagnostic procedures and in-hospital *** hospital discharge,patients were followed up for 6 *** statistical methods were used to examine the patterns of management and *** Overall,68.7%,26.9%and 4.4%were ischaemic stroke(IS),intracerebral haemorrhage(ICH),and subarachnoid haemorrhage(SAH),*** 20%were managed in a dedicated stroke *** IS,1.3%received thrombolysis within 3 hours after symptom onset,whereas the proportions of receiving in-hospital antiplatelet therapy,neuroprotective agents and traditional Chinese medicines(TCM)were 88.4%,69.7%and 70.6%,*** ICH,63.3%and 36.3%received neuroprotective agents and TCM in hospital,*** discharge,70.7%and 38.0%of the patients with IS were given antiplatelet and statin therapies,respectively,decreasing to 64.8%and 23.9%,respectively,at 6 ***-hospital mortality was 3.2%,9.3%and 10.1%for IS,ICH and SAH,respectively,with a further 8.6%,18.2%and 22.0%,respectively,died by 6 ***,in-hospital recurrence rate was 2.6%,1.9%and 7.2%for IS,ICH and SAH,respectively,with a further 8.0%,5.1%and 7.5%,respectively,recurred by 6 *** In China,the mortality rate of stroke is lower than that reported from west populations,though most strokes are not managed in specialised stroke *** is widespread use of some unproven therapies but limited proven treatments,especially after discharge,leading to unnecessary recurrent risks.